Table
1: Comparisons
of FDG uptake on skeletal and cardiac involvement pre-treatment vs post-treatment.
Skeletal Involvement |
August 2013 (FDG uptake-SUV max) |
February 2014 (FDG uptake – SUV max) |
Humeral
heads |
Right
10.2 |
Right
6.0 |
Distal humeri |
Right
14.6 Left
9.2 |
Right
9.3 Left
6.2 |
Femoral
greater trochanter |
Right
25.1 Left
24.0 |
Right
14.2 Left
13.6 |
Tibia
plateau |
Right
25.3 Left
29.2 |
Right
19.9 Left
17.7 |
Distal tibial |
Right
20.1 Left
21.7 |
Right
9.2 Left 10 |
Calcaneal
|
Right
16.8 Left
17.1 |
Right
10.1 Left
10.7 |
Cardiac Involvement |
August 2013 (FDG
uptake-SUV max) |
February 2014 (FDG
uptake – SUV max) |
Thoracic
Aorta |
3.31 |
2.87 |
Left
main/left circumflex/right coronary arteries |
Unable
to quantify |
Unable
to quantify |
Pulmonary Involvement |
Small
volume mildly FDG avid mediastinal nodes in the prevascular and precarinal
stations |
No
change |
Pleural
|
Pleural
thickening both lower lobes |
Stable
pleural thickening both lower lobes |
Abdomen and Pelvis Celiac and Superior mesenteric arteries |
Stable
non metabolic |
Stable
non metabolic |
Head and Neck |
No hypermetabolic uptake of cervical nodes, nasopharynx, oropharynx and thyroid |
No hypermetabolic uptake of cervical nodes, nasopharynx, oropharynx and thyroid |
Brain |
No
uptake |
No
uptake |